View Older Stories

Apr 11, 2023 09:04AM Acadia Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference

Jun 15, 2022 11:06AM Needham & Company Stays Sidelined on Acadia Pharmaceuticals (ACAD), 'No Major Surprises in AdCom Docs; FDA Concerns Stand'

Apr 19, 2022 06:58AM Needham & Company Reiterates Hold Rating on Acadia Pharmaceuticals (ACAD) on ACP-044 Failure, Sees Minimal Impact, "Wouldn't Be Surprised if the Stock Bounces"

Apr 4, 2022 07:06AM Needham & Company Reiterates Acadia Pharmaceuticals (ACAD) at Hold Following AMX0035 Data, Notes It's Hard to Grasp Likelihood of Approval

Mar 10, 2022 04:05PM Acadia Pharmaceuticals to Present at the 1st Annual Needham Virtual Neuroscience Forum on March 16, 2022

Mar 9, 2022 09:27AM Needham & Company Reiterates Hold Rating on Acadia Pharmaceuticals (ACAD), Sees 50% Chance of pimavanserin Approval in Alzheimer's

Mar 1, 2022 06:36AM Needham & Company Reiterates Acadia Pharmaceuticals (ACAD) at Hold, FDA Decision on pimavanserin's ADP sNDA Remains a Wildcard

Dec 7, 2021 06:14AM Acadia’s (ACAD) Rett Syndrome Data Adequate for Approval, Stock Gains Are Justified - Analyst

Sep 22, 2021 04:08PM Needham & Company Assumes Acadia Pharmaceuticals (ACAD) at Hold

Aug 5, 2021 06:30AM Acadia Pharmaceuticals (ACAD) PT Lowered to $26 at Needham & Company

Apr 5, 2021 12:28PM Acadia (ACAD) PT Lowered to $30 at Needham & Company, Keeps 'Buy' as News Was Mostly Expected

Jul 21, 2020 09:30AM Pre-Open Movers 07/21: (NBEV) (LXRX) (OMI) Higher; (ACAD) (PIRS) (CTSO) Lower (more...)

Sep 20, 2019 04:05PM ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Sep 18, 2019 05:44AM Acadia Pharma (ACAD) Prices 6.25M Share Offering at $40/Sh

Sep 17, 2019 11:00PM ACADIA Pharmaceuticals Prices Public Offering of Common Stock

Sep 9, 2019 10:57AM Acadia Pharmaceuticals (ACAD) PT Raised to 'Street High' $60 at Needham & Company

Jul 23, 2019 06:38AM Acadia Pharmaceuticals (ACAD) PT Lowered to $34 at Needham & Company Following Nuplazid Schizophrenia Miss

Apr 2, 2019 09:00AM ACADIA Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 9, 2019

Feb 27, 2019 08:00AM Acadia Pharma (ACAD) Guidance Misses, PT To $40 At Needham

Nov 30, 2018 04:05PM ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Nov 28, 2018 05:48AM Acadia Pharma (ACAD) Prices 16.176M Share Common Offering at $17/Sh

Nov 27, 2018 09:20PM ACADIA Pharmaceuticals Prices Public Offering of Common Stock

Aug 6, 2018 09:27AM Pre-Open Movers 08/06: (SEAS) (VTL) (CTWS) Higher; (OVID) (BID) (PX) Lower (more...)

Mar 20, 2018 09:00AM ACADIA Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference on March 27, 2018

Apr 5, 2017 12:22PM Needham & Company Reiterates Buy Rating and $49 PT on ACADIA Pharmaceuticals (ACAD) Following Presentation at Needham Healthcare Conference

Mar 29, 2017 09:00AM ACADIA Pharmaceuticals to Present at Needham & Company’s 16th Annual Healthcare Conference on April 5, 2017

Mar 1, 2017 07:17AM Needham and Company Reiterates Buy Rating and $49 PT on Acadia Pharmaceuticals (ACAD) Following Strong 4Q Nuplazid Sales; 'Plans to Expand Sales Force'

Dec 20, 2016 10:36AM Needham & Company Doesn't See Any Regulatory Concern Related to Acadia (ACAD) Phase 2 Nuplazid Results

Oct 24, 2016 08:37AM Acadia Pharma (ACAD): Nuplazid KOL Follow-Up Call - Needham

Aug 23, 2016 04:40PM ACADIA Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

Aug 10, 2016 06:26AM Acadia Pharma (ACAD) Prices 6.06M Common Stock Offering at $33/Share

Aug 9, 2016 08:50PM ACADIA Pharmaceuticals Prices Public Offering of Common Stock

Aug 5, 2016 08:19AM Needham & Company Affirms Acadia Pharma (ACAD) at 'Buy'; Says Initial Nuplazid Sales Affected by Sampling

Jun 24, 2016 11:13AM Needham & Company Weighs in on Brexit Biotech Impact (ACAD) (GILD0 (ICPT) (SGEN)

Apr 6, 2016 09:00AM ACADIA Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016

Mar 30, 2016 06:49AM Needham & Company Remains Bullish on Acadia Pharma (ACAD) Following Positive FDA Vote on Nuplazid

Mar 15, 2016 08:24AM Upcoming FDA AdCom a Catalyst For ACADIA Pharma (ACAD) - Needham & Company

Jan 6, 2016 10:42PM Acadia Pharma (ACAD) Prices 10.34M Shares at $29

Jan 6, 2016 09:35PM ACADIA Pharmaceuticals Prices Public Offering of Common Stock

Aug 7, 2015 08:36AM Acadia Pharmaceuticals (ACAD) PT Raised to $49 at Needham & Company Ahead of NDA Submission

Apr 7, 2015 09:00AM ACADIA Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference on April 14, 2015

Mar 12, 2015 07:14AM Acadia Pharmaceuticals (ACAD) 'Buy' Retained at Needham & Company Despite NDA, CEO News; PT to $38

Dec 22, 2014 07:20AM Acadia Pharmaceuticals (ACAD) PT Raised to $40 at Needham & Company

May 15, 2014 10:28AM Notable Analyst Rating Changes 05/15: (PLUG) (PTX) (TWTR) Upgraded; (BMY) (HII) (CXP) Downgraded

May 7, 2014 07:55AM Acadia Pharmaceuticals (ACAD) Bullish Stance Reiterated at Needham & Company Post Q1

Aug 7, 2013 08:52AM Acadia (ACAD) PT Lifted to $26 at Needham & Company

May 15, 2013 09:33AM StreetInsider.com Pre-Open Movers 5/15: (MFLR) (CHCI) (SPWR) Higher; (XONE) (DE) (P) Lower (more...)

May 15, 2013 08:03AM Acadia Pharmaceuticals, (ACAD) Prices 8M Share Offering at $12.50/Sh

May 14, 2013 06:01PM Streetinsider.com After-Hours Movers 05/14: (MFLR) (TCXX) (VIPS) Higher; (XONE) (RMTI) (ACAD) Lower (more...)

May 14, 2013 04:04PM Acadia Pharmaceuticals (ACAD) Announces Stock Offering

View Older Stories